MEDICINOVA INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Medicinova Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2018 to Q3 2024.
  • Medicinova Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $505K, a 130% increase year-over-year.
  • Medicinova Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $690K, a 35.9% decline year-over-year.
  • Medicinova Inc annual Share-based Payment Arrangement, Expense for 2023 was $711K, a 10.6% increase from 2022.
  • Medicinova Inc annual Share-based Payment Arrangement, Expense for 2022 was $643K, a 62.6% decline from 2021.
  • Medicinova Inc annual Share-based Payment Arrangement, Expense for 2021 was $1.72M, a 45.9% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $690K $505K +$286K +130% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $405K $207K -$118K -36.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $523K $215K -$188K -46.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $711K -$237K -$366K -285% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $1.08M $219K +$60.8K +38.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $1.02M $326K +$51.2K +18.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $965K $403K +$322K +398% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $643K $129K +$886K Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 -$243K $158K -$421K -72.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $178K $275K -$481K -63.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $659K $81.1K -$1.06M -92.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $1.72M -$757K -$1.16M -290% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-03-28
Q3 2021 $2.87M $579K -$455K -44% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $3.33M $756K -$391K -34.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $3.72M $1.14M +$543K +91.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $3.18M $398K +$1.2M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-16
Q3 2020 $1.97M $1.03M +$660K +177% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $1.31M $1.15M -$695K -37.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $2.01M $596K -$2.1M -77.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 $4.11M -$803K Oct 1, 2019 Dec 31, 2019 10-K 2021-02-19
Q3 2019 $374K -$4.35M -92.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-26
Q2 2019 $1.84M +$1.02M +124% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-28
Q1 2019 $2.7M Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-23
Q3 2018 $4.73M Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-25
Q2 2018 $823K Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.